Vasomedical Inc.

Related Content

News
FDA Reclassifies ECP Devices for Refractory Angina as Class II

January 7, 2014 — Vasomedical Inc., maker of EECP (enhanced external counterpulsation) Therapy systems, announced that ...

Home January 07, 2014
arrow
Technology
Combined Holter Records Both ECG, Blood Pressure

April 13, 2010 – The U.S. Food and Drug Administration (FDA) recently cleared a combined electrocardiogram (ECG) Holter ...

Home April 13, 2010
arrow
Technology
Vasomedical Introduces BIOX Holter Monitor, Analysis Software

April 10, 2009 - Vasomedical Inc. this week said it received FDA 510(k) clearance to market Vasomedical-BIOX 1305 ECG ...

Home April 10, 2009
arrow
News
Results of Two Studies on Counterpulsation Therapy to Promote Collateral Growth Presented at the ACC

April 2, 2009 - Vasomedical Inc. this week conducted two presentations on the beneficial effects of EECP external ...

Home April 02, 2009
arrow
News
Medicare Increases Rates for Vasomedical EECP Therapy for 2008

January 25, 2008 - Medicare has increased reimbursement payment rates for EECP therapy for 2008, effective immediately ...

Home January 24, 2008
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now